MétaCan
Menu
Back to cohort
Record W4411964411 · doi:10.1016/j.ekir.2025.06.043

A Within-Trial Economic Evaluation of a Patient Navigator Program in Children With CKD

2025· article· en· W4411964411 on OpenAlexaff
W. T. Chen, Germaine Wong, Kirsten Howard, Chandana Guha, Anita van Zwieten, Andrea N. Natsky, Kylie‐Ann Mallitt, Rabia Khalid, Anna Francis, Siah Kim, Armando Teixeira-Pinto, Amélie Bernier-Jean, David W. Johnson, Deirdré Hahn, Elizabeth G. Ryan, Hugh J. McCarthy, Charani Kiriwandeniya, Nicholas Larkins, Patrina Caldwell, Reginald Woodleigh, Simon Carter, Seán Kennedy, Stephen I. Alexander, Steven McTaggart, Jonathan C. Craig, Carmel M. Hawley, Martin Howell, David W. Johnson, Donna Reidlinger, Elaine Pascoe, Elizabeth Ryan, Fiona Mackie, Julie Varghese, Liza A. Vergara, Luke Macauley, Michelle Irving, Reg Woodleigh, Sean Kennedy, Shilpanjali Jesudason, Stephen Alexander, Steve McTaggart, Charani Kiriwandeniya

Bibliographic record

VenueKidney International Reports · 2025
Typearticle
Languageen
FieldMedicine
TopicDialysis and Renal Disease Management
Canadian institutionsCentre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal
FundersFaculty of Medicine and Health, University of SydneyNational Health and Medical Research CouncilMedical Research CouncilUniversity of QueenslandUniversity of Sydney
KeywordsMedicineKidney diseaseDiseaseIntensive care medicinePediatricsPhysical therapyInternal medicine

Abstract

fetched live from OpenAlex

Introduction The NAVKIDS2 trial was a patient navigation program for children and their caregivers living with chronic kidney disease (CKD) in Australia. We conducted a within-trial economic evaluation to describe the cost-effectiveness of patient navigation compared to standard care. Methods Cost and resource utilization data were prospectively collected over 6 months, from a healthcare funder perspective. Costs are reported in Australian dollars. Quality of life data was collected from 0 to 6 months. Incremental cost-effectiveness ratios (ICERs) were reported as the additional cost per quality-adjusted life years (QALYs) gained. Results Over the 6-month period, total per patient costs were higher in the patient navigation group compared to those in the standard care group ($10,249 vs $9,368 respectively, p<0.001). There was no significant difference in mean healthcare costs between the two groups ($9,848 vs $9,368 respectively, p=0.98), but the intervention group incurred an additional cost of $1,075 per person for the patient navigator. There was no significant difference in total QALYs over 6 months between patient navigation and standard care groups (0.33 vs 0.30 respectively, p=0.11). The ICER for the intervention compared to usual care was $41,960/QALY gained with a wide 95% confidence interval (-$300,123 to +$769,958) indicating substantial uncertainty. Conclusion The economic evaluation found that the cost of patient navigators is relatively low compared to total healthcare costs but there is considerable uncertainty regarding the cost-effectiveness of the intervention. Further research is needed to evaluate long-term cost-effectiveness as well as potential impacts on health outcomes and healthcare utilization.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.018
metaresearch head score (Gemma)0.030
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.018
Threshold uncertainty score0.093

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0180.030
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0030.007
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0020.002
Open science0.0010.001
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0060.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.311
Teacher spread0.302 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueKidney International ReportsSame topicDialysis and Renal Disease ManagementFrench-language works237,207